GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Faes Farma SA (STU:FFEA) » Definitions » Other Income (Expense)

Faes Farma (STU:FFEA) Other Income (Expense) : €-10.1 Mil (TTM As of Jun. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Faes Farma Other Income (Expense)?

Faes Farma's other income expense for the Faes Farma's pretax income for the three months ended in Jun. 2024 was €-10.1 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2024 was €-10.1 Mil.

Faes Farma Other Income (Expense) Historical Data

The historical data trend for Faes Farma's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Faes Farma Other Income (Expense) Chart

Faes Farma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.96 -7.29 -4.29 -0.38 -1.29

Faes Farma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Mar24 Jun24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -9.47 - - -10.07

Faes Farma Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-10.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Faes Farma  (STU:FFEA) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Faes Farma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Faes Farma SA (STU:FFEA) » Definitions » Other Income (Expense)
Comparable Companies
XMAD:ALM XMAD:RJF XMAD:LAB ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA XSWX:SDZ NSE:DIVISLAB HKSE:03692 SZSE:000538 NSE:TORNTPHARM VTRS BOM:500124 BOM:532321 NBIX BOM:543904
Traded in Other Exchanges
0K9H:UK FAE:Spain FFEA:Germany
Address
Maximo Aguirre, 14, Leioa, Vizcaya, ESP, 48940
Website
http://www.faes.es
Faes Farma SA is a pharmaceutical company that specializes in the research, production, distribution, and sale of prescription and generic drugs, over-the-counter medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The company develops new drugs for the treatment of allergy, venous insufficiency, and irritable bowel syndrome. It also provides animal nutrition products. Faes Farma exports its products to more than 60 countries and has operations in Spain, Portugal, Chile, and Mexico, among others.

Faes Farma Headlines

No Headlines